Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

(2018) Akinori Nakamura et al.   NATURE

Comparing Brain Amyloid Deposition, Glucose Metabolism, and Atrophy in Mild Cognitive Impairment with and without a Family History of Dementia

(2018) Lisa Mosconi et al.   JOURNAL OF ALZHEIMERS DISEASE

Brain [18F]FDDNP Binding and Glucose Metabolism in Advanced Elderly Healthy Subjects and Alzheimer's Disease Patients

(2018) Clovis Tauber et al.   JOURNAL OF ALZHEIMERS DISEASE

Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)

(2018) Itziar de Rojas et al.   Alzheimers Research & Therapy

Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype

(2017) Ana Espinosa et al.   JOURNAL OF ALZHEIMERS DISEASE

Plasma Amyloid-β as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging

(2017) James K. Lui et al.   JOURNAL OF ALZHEIMERS DISEASE

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

(2016) Bruno Dubois et al.   Alzheimers & Dementia

Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in Plasma

(2016) Virginia Pérez-Grijalba et al.   JOURNAL OF ALZHEIMERS DISEASE

Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology

(2016) Philip S. Insel et al.   NEUROLOGY

Plasma β-amyloid in Alzheimer’s disease and vascular disease

(2016) Shorena Janelidze et al.   Scientific Reports

Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study

(2015) Vincent Chouraki et al.   Alzheimers & Dementia

Association of hypometabolism and amyloid levels in aging, normal subjects

(2014) V. J. Lowe et al.   NEUROLOGY

The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly

(2013) Miranka Wirth et al.   Alzheimers & Dementia

Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease

(2013) Alan Rembach et al.   Alzheimers & Dementia

Association of plasma and cortical amyloid beta is modulated by APOE ε4 status

(2013) Shanker Swaminathan et al.   Alzheimers & Dementia

Design of a comprehensive Alzheimer’s disease clinic and research center in Spain to meet critical patient and family needs

(2013) Mercè Boada et al.   Alzheimers & Dementia

Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer’s disease dementia

(2013) Javier Arbizu et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer’s disease

(2013) Shizuo Hatashita et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

White matter lesion load is associated with resting state functional MRI activity and amyloid pet but not FDG in mild cognitive impairment and early alzheimer's disease patients

(2013) Yongxia Zhou et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Biomarker Modeling of Alzheimer’s Disease

(2013) Clifford R. Jack et al.   NEURON

Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old

(2013) Montserrat Alegret et al.   PLoS One

Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia

(2012) Peder Buchhave   ARCHIVES OF GENERAL PSYCHIATRY

A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease

(2012) Agneta Nordberg et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Region-Specific Hierarchy between Atrophy, Hypometabolism, and  -Amyloid (A ) Load in Alzheimer's Disease Dementia

(2012) R. La Joie et al.   JOURNAL OF NEUROSCIENCE

Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers

(2012) Jennifer L. Shaffer et al.   RADIOLOGY

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden

(2011) Alexander Drzezga et al.   BRAIN

Normative data of a brief neuropsychological battery for Spanish individuals older than 49

(2011) Montserrat Alegret et al.   JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY

Characterizing Alzheimer's disease using a hypometabolic convergence index

(2011) Kewei Chen et al.   NEUROIMAGE

Plasma A  and PET PiB binding are inversely related in mild cognitive impairment

(2011) D. P. Devanand et al.   NEUROLOGY

Cognition, glucose metabolism and amyloid burden in Alzheimer's disease

(2010) Ansgar J. Furst et al.   NEUROBIOLOGY OF AGING

Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease

(2010) Ahmadul Kadir et al.   NEUROBIOLOGY OF AGING

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI

(2009) Susan M. Landau et al.   NEUROBIOLOGY OF AGING

Association of plasma amyloid   with risk of dementia: The prospective Three-City Study

(2009) J. -C. Lambert et al.   NEUROLOGY

Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

(2008) Oskar Hansson et al.   NEUROBIOLOGY OF AGING

Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study

(2008) O. L. Lopez et al.   NEUROLOGY

Peripheral A  subspecies as risk biomarkers of Alzheimer's disease

(2008) N. Schupf et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA